logo
Select company
Select metric
88.23%Debt to Assets Ratio
VS
Market
4
Sector
5
Industry
6
History
-
$ 4.81Close
$ 2.05 - $ 8.48 52-Week Range
Ticker Information

Ticker

ADVM

Company Name

ADVERUM BIOTECHNOLOGIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ADVERUM BIOTECHNOLOGIES INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADVM - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 96.18M$ 84.86M88.23%
3/31/2025$ 137.65M$ 85.95M62.44%
12/31/2024$ 179.84M$ 86.04M47.84%
9/30/2024$ 234.38M$ 62.6M26.71%
6/30/2024$ 253.8M$ 63.31M24.95%
3/31/2024$ 267.83M$ 63.99M23.89%
12/31/2023$ 173.01M$ 64.63M37.35%
9/30/2023$ 196.77M$ 65.2M33.14%
6/30/2023$ 241.43M$ 65.76M27.24%
3/31/2023$ 275.58M$ 71.35M25.89%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) Debt to Assets stands at 5.27%.
  • Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average Debt to Assets has been 29.73%.
  • The median Debt to Assets for ADVERUM BIOTECHNOLOGIES INC during this period was 26.17%
  • ADVERUM BIOTECHNOLOGIES INC reached its highest Debt to Assets over the past 5 years at 88.23%.
  • The lowest Debt to Assets recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe 5.27%

ADVERUM BIOTECHNOLOGIES INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
DTIL : PRECISION BIOSCIENCES INC 27.03%RANI : RANI THERAPEUTICS HOLDINGS INC 127.93%RNXT : RENOVORX INC 1.18%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC 3.35%PLUR : PLURI INC 88.02%LSTA : LISATA THERAPEUTICS INC 0%IGC : IGC PHARMA INC 1.76%CLSD : CLEARSIDE BIOMEDICAL INC 366.78%COEP : COEPTIS THERAPEUTICS HOLDINGS INC 10.93%RLYB : RALLYBIO CORP 0.11%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Debt [ $ 26.75M ] / Assets [ $ 507.71M ]
(=) Debt to Assets [ 5.27% ]

ADVM - Debt to Assets Ratio, Last 5 years

5.27%

Minimum

Sep 30, 2020

88.23%

Maximum

Jun 30, 2025

29.73%

Average

26.17%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.33% with a standard deviation of 24.49%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.37K
min0%
max116.6%
average26.33%
median21.09%
std24.49%